Paris, France

Marc Le Bret

This inventor holds 1 USPTO granted patent. Top assignees: Bioalliance Pharma, Centre National De La Recherche Scientifique, Institut Gustave Roussy. Active years: 2006.


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marc Le Bret: Innovator in Medicinal Chemistry

Introduction

Marc Le Bret is a distinguished inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on quinoline derivatives. His research has implications for the development of new medicaments, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Marc Le Bret holds 1 patent for his invention titled "Quinoline derivatives process of synthesis and medicaments containing these derivatives." This patent relates to derivatives corresponding to a specific formula, which has potential applications in the pharmaceutical industry.

Career Highlights

Throughout his career, Marc has worked with notable organizations, including the Institut Gustave Roussy and Bioalliance Pharma. His experience in these institutions has allowed him to collaborate on various projects aimed at improving medicinal therapies.

Collaborations

Marc has had the opportunity to work alongside esteemed colleagues such as Jean-Francois Mouscadet and Hervé Leh. These collaborations have enriched his research and contributed to the advancement of his innovative ideas.

Conclusion

Marc Le Bret's contributions to medicinal chemistry through his patent on quinoline derivatives exemplify his dedication to innovation in healthcare. His work continues to inspire advancements in the field, highlighting the importance of research and collaboration in developing effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…